Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
New Melocules

934660-94-3 Cobimetinib

934660-94-3 Cobimetinib

Cobimetinib (GDC-0973, XL-518) is a MEK inhibitor which is used in combination with vemurafenib, a BRAF inhibitor, to treat melanoma.

Synonyms: XL518;GDC-0973;RG7420;[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)aMino]phenyl][3-hydroxy-3-[(2S)-2-piperidinyl]-1-azetidinyl]Methanone;GDC-0973(XL-518);(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylaMino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)Methanone;XL518 ,GDC-0973;CobiMetinib
CAS: 934660-93-2
MF: C21H21F3IN3O2
MW: 531.3100196

GMP for 934660-94-3 Cobimetinib is not available. DMF for 934660-94-3 Cobimetinib is under preparation.
 
Disclaimer:Those products (High Purity 934660-94-3 Cobimetinib) are for lab analytical & research purposes only.